Stability and neutralising capacity of SARS-CoV-2-specific antibodies in convalescent plasma

Lancet Microbe. 2020 Jun;1(2):e63. doi: 10.1016/S2666-5247(20)30037-9. Epub 2020 Jun 8.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antibodies, Viral / therapeutic use
  • COVID-19 Serotherapy
  • COVID-19* / therapy
  • Humans
  • Immunization, Passive
  • Immunoglobulin M
  • SARS-CoV-2*

Substances

  • Antibodies, Viral
  • Immunoglobulin M